people are realizing the risk reward scenario here and the fact that it's a steal at these prices, with approval we are looking at $7 to $10 range, and that approval is looking more and more like it's going to happen with a former FDA head running the show.
I think you'd have to eclipse that vol if you're to wipe through the crl bag-holders, no? At some point they'll lighten up and we'll see multipenny jumps.
Market Data 
Markets 
AI
